Board of Directors
Wei-Wu He, Ph.D.
Chairman & Chief Executive Officer
Dr. He has served as chairman to the board of directors and CEO of CASI since 2019, as executive chairman from February, 2018, and as chairman from February 2012. Prior to CASI, He was chairman and CEO of OriGene.
Dr. He is also the founder and general partner of Emerging Technology Partners, LLC, a life sciences focused venture fund established in 2000. Dr. He has been involved in founding or funding over 100 biotech companies throughout his career, including CASI, OriGene, GENETRON, and EdiGene.
In the earlier part of his career, Dr. He was one of the first few scientists at Human Genome Sciences, and prior to that, was a research fellow at Massachusetts General Hospital and Mayo Clinic. Dr. He is the author of more than 30 research publications and the inventor of 32 issued patents. Dr. He received his Ph.D. from Baylor College of Medicine and MBA from The Wharton School of University of Pennsylvania.
